TY - JOUR
T1 - Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors
AU - Kolko, Miriam
AU - de Turco, Elena B
AU - Diemer, Nils Henrik
AU - Bazan, Nicolas G
PY - 2002/10/28
Y1 - 2002/10/28
N2 - To define the significance of glutamate ionotropic receptors in sPLA -mediated neuronal cell death we used the NMDA receptor antagonist MK-801 and the AMPA receptor antagonist PNQX. In primary neuronal cell cultures both MK-801 and PNQX inhibited sPLA - and glutamate-induced neuronal death. [ H]Arachidonic acid release induced by both sPLA and glutamate was partially blocked by MK-801, indicating that the glutamate-NMDA-cPLA pathway contributes to sPLA -induced arachidonic acid release. Systemic administration of MK-801 to rats that had sPLA injected into the right striatum significantly decreased neuronal cell death. We conclude that glutamatergic synaptic activity modulates sPLA -induced neuronal cell death.
AB - To define the significance of glutamate ionotropic receptors in sPLA -mediated neuronal cell death we used the NMDA receptor antagonist MK-801 and the AMPA receptor antagonist PNQX. In primary neuronal cell cultures both MK-801 and PNQX inhibited sPLA - and glutamate-induced neuronal death. [ H]Arachidonic acid release induced by both sPLA and glutamate was partially blocked by MK-801, indicating that the glutamate-NMDA-cPLA pathway contributes to sPLA -induced arachidonic acid release. Systemic administration of MK-801 to rats that had sPLA injected into the right striatum significantly decreased neuronal cell death. We conclude that glutamatergic synaptic activity modulates sPLA -induced neuronal cell death.
KW - Animals
KW - Arachidonic Acid/metabolism
KW - Astrocytes/drug effects
KW - Body Temperature/drug effects
KW - Brain/enzymology
KW - Cell Death/drug effects
KW - Cells, Cultured
KW - Cerebral Infarction/drug therapy
KW - Dizocilpine Maleate/pharmacology
KW - Dose-Response Relationship, Drug
KW - Excitatory Amino Acid Antagonists/pharmacology
KW - Excitatory Amino Acids/metabolism
KW - Fetus
KW - Group II Phospholipases A2
KW - Humans
KW - Neostriatum/drug effects
KW - Neurons/drug effects
KW - Phospholipases A/metabolism
KW - Phospholipases A2
KW - Quinoxalines/pharmacology
KW - Rats
KW - Rats, Wistar
KW - Receptors, AMPA/drug effects
KW - Receptors, N-Methyl-D-Aspartate/drug effects
UR - https://www.scopus.com/pages/publications/0037190825
U2 - 10.1097/00001756-200210280-00026
DO - 10.1097/00001756-200210280-00026
M3 - Journal article
C2 - 12395100
SN - 0959-4965
VL - 13
SP - 1963
EP - 1966
JO - NeuroReport
JF - NeuroReport
IS - 15
ER -